Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
InnoCare Announces Orphan Drug Designation of Gunagrabtinib by US FDA for Treatment of Cholangiocarcinoma 2021-06-17 11:31
Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment 2021-06-16 13:08
Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci 2021-06-16 10:14
BIO Digital Taiwan Day will be held on June 22 2021-06-15 23:00
The U.S. FDA Approved IND Application to Investigate Combination of Asieris' APL-1202 and BeiGene's Tislelizumab as Neoadjuvant Therapy for MIBC Patients 2021-06-15 08:46
Happiness Biotech Signed Agreement To Distribute Volkswagen Electric Vehicles 2021-06-14 20:00
Bridge Biotherapeutics Announces the Initiation of Patient Dosing in the Proof of Clinical Principle Study for BBT-401, an Investigational Drug for Ulcerative Colitis 2021-06-14 06:00
OliPass Expands Scientific Advisory Board by Inviting Experts in Pain To Bolster Phase 2 Clinical Trial Design and Management 2021-06-10 21:00
Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer 2021-06-09 21:00
Cell Care Joins the Generate Life Sciences Family to Create a Global Platform 2021-06-03 06:00
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement 2021-06-02 21:00
Portonbio announced strategic cooperation with KAEDI to accelerate the R&D and production of CAR-T drugs 2021-06-02 20:10
PharmAbcine to Present at the BIO Digital International Convention 2021 2021-06-02 20:00
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate 2021-06-02 19:00
ImmVira will present the U.S. Clinical Phase I Study Results of MVR-T3011 via Intratumoral Administration at ASCO 2021 2021-06-02 16:14
Bridge Biotherapeutics Announces the Initiation of the Proof of Mechanism Study for BBT-401 in Patients with Ulcerative Colitis; Rectal Delivery of Drug to Target Site 2021-06-02 06:00
Eucure Biopharma to Present Findings From Anti-CD40 and Anti-CTLA-4 mAb Clinical Trials at the 2021 ASCO Meeting 2021-06-02 01:28
GenScript ProBio and Neoletix signed a letter of intent on clinical and commercial production of recombinant human coagulation factor VIII 2021-06-01 21:00
Neurophth Therapeutics and Hopstem Biotechnology Announce Strategic Partnership to Develop Human Induced Pluripotent Stem Cell-Derived Therapies for the Treatment of Ocular Diseases 2021-06-01 19:50
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services 2021-05-31 19:00
1 86 87 88 89 90 203